Health
Combination of anti-HER2 breast cancer therapy and checkpoint inhibitor provides no benefit – News-Medical.Net
Adding an immune checkpoint inhibitor to anti-HER2 treatment in breast cancer does not improve pathological complete response…
Adding an immune checkpoint inhibitor to anti-HER2 treatment in breast cancer does not improve pathological complete response (pCR), according to the primary analysis of the IMpassion050 trial presented today during the ESMO Virtual Plenary.
The phase III…
Continue Reading
-
Noosa News24 hours agoAudit slams state school fees
-
General10 hours agoUN special envoy Julie Bishop makes first trip to Myanmar after earthquake
-
General17 hours agoVolodymyr Zelenskyy says 155 Chinese nationals fighting with Russia in Ukraine
-
Noosa News12 hours agoCity of Moreton Bay throws homeless people’s tents into garbage trucks